A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy.
about
A review of anti-VEGF agents for proliferative diabetic retinopathyDiabetic macular oedema: clinical risk factors and emerging genetic influences.The outcomes and prognostic factors of vitrectomy in chronic diabetic traction macular detachmentIdentification of novel drug targets for the treatment of diabetic retinopathy.New Therapeutic Approaches in Diabetic Retinopathy.Multicolor pattern scan laser for diabetic retinopathy with cataract.Ocular pharmacokinetics of bevacizumab in vitrectomized eyes with silicone oil tamponade.Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy.Bevacizumab as an adjunct to vitreoretinal surgery for diabetic retinopathy in East Africa.Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.Surgical treatment for diabetic vitreoretinal diseases: a review.Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab.Improving care and increasing efficiency-challenges in the care of chronic eye diseases.Intraocular surgery in a large diabetes patient population: risk factors and surgical results.Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study).Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.
P2860
Q27025643-9D5E5AB4-7753-4823-8E30-602E4DF81401Q30234323-EF13E7CF-F963-41DF-907D-B7719175B54DQ30275957-CFCEA0FF-EE1C-437A-A3AC-3FAF28125A77Q31134280-04B8B3F2-3018-4EB7-B58F-F87B8D0DED0AQ33583037-2C4474BB-BE9C-41D7-AED9-8F3B17B53A10Q34063072-9B9858FD-9FC1-43C1-A20C-39101ED899A8Q36154521-9D5F1EC1-D158-47BD-8E8D-97065E1583F5Q37053882-81B655F8-56BB-456C-B62D-5D54456ACF26Q37317228-2EC6B155-7CDC-44B6-9693-C524949AD3DDQ37477129-67A5E3B8-F7BC-4CD4-B28B-9619191324B2Q37997307-B706FE91-3741-4CB1-9668-BE566B323513Q38793330-C1429037-668E-40B8-840E-645F504DEC96Q40196662-F16BB643-D97F-4222-A305-911BFBCCA0BEQ42733207-E7A14148-7031-4130-BF5B-F0D3CFA67CFDQ44920544-C59A5985-06EE-4F8F-ADC5-8A132A45D099Q47300238-8E2FE5A7-7DF2-43DE-8A6D-51433ACAD161Q51006402-D8A6AA35-25CC-4C71-B30C-F59D55E9ABAFQ54942391-88B39458-BF0D-40BA-B1E0-D3D8BE9345B2
P2860
A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A systematic review and meta-a ...... r severe diabetic retinopathy.
@ast
A systematic review and meta-a ...... r severe diabetic retinopathy.
@en
type
label
A systematic review and meta-a ...... r severe diabetic retinopathy.
@ast
A systematic review and meta-a ...... r severe diabetic retinopathy.
@en
prefLabel
A systematic review and meta-a ...... r severe diabetic retinopathy.
@ast
A systematic review and meta-a ...... r severe diabetic retinopathy.
@en
P2093
P2860
P31
P921
P356
P1476
A systematic review and meta-a ...... r severe diabetic retinopathy.
@en
P2093
Li-Quan Zhao
Pei-Quan Zhao
Yi-Qian Hu
P2860
P304
P356
10.1136/BJO.2010.189514
P407
P5008
P577
2011-01-27T00:00:00Z
2011-09-01T00:00:00Z